Detailed preoperative evaluation is essential in prevention of perioperative complications. As thorough anamnesis, physical examination and standard laboratory investigation do not contribute much in prediction of perioperative complications and outcome, and detection of tumor markers is also insufficient in means of prognosis, some molecular marker have emerged lately as prognostic markers in surgery. Recent data on pathophysiological processes stress response, derangements of hemostasis, in sepsis or in thromboembolism as well as in malignancy, indicate that presence or elevation of some molecular markers of fibrinolysis can indicate possibility of perioperative complications and even predict outcome. As it is evident that neoplastic cells enhance thrombin and other procoagulant production, detection of degree of activation of coagulation and fibrinolysis can contribute in prediction of treatment outcome in patients with bladder carcinoma scheduled for radical surgical procedures.
T he role of D-dimer, the final product and only specific marker of fibrinolysis is thoroughly evaluated in studies of thromboembolism, but still investigated in studies of progression of systemic inflammatory responce and multiple organ disfunction in critically ill and in determination of progression of carcinoma. Endothelial dysfunction in thrombosis, inflammation and in malignancy has the same pathophysiological origin: thrombin generation induction by tissue factor, disfunction of coagulation and derrangement of fibrinolysis.
In malignancy interaction of inflammation and coagulation results in systemic inflammatory responce syndrome that leads to microvascular thrombosis and modulation of inflammation itself. Intravascular deposition of fibrine and microagregation of thrombocytes, neutrofile and red blood cells can lead to tissue ishemia and multiple organ failure 1, 2 . In malignancy and in radical surgery with significant tissue distruction and derrangement of circulation, direct activation of coagulation occures with interaction of endotelial microparticules and proinflammatory cytokines from malignantly altered tissues 3, 4 . Subclinical activation of coagulation in malignancy is proven through direct procoagulant activity of malignant cells, through direct cellular interaction and through cytokine production 5 . Cellular ineraction and mediator action on endothelium modulates vascular tone, platelet adhesionm inflammation, fibrinolysis and vascular growth 6 . All mentioned give reason for recent studies that track progression of malignancy through evaluation of coagulation markers, and they indicate that degree of coagulation activation can give insight in advance of malignancy, poor prognosis and short survivial of surgical patients 7, 8, 9, 10 . In patients with urologic malignancy data indicate elevation of markers of fibrinolysis (fibrinogen, F1+2, D-dimer) in prostate cancer patients and in patients 11 that underwent radical cystectomy connention of increased values of urokinase-type plasminogen activator (u-PA) with degree of lymphovascular invasion, tumor progression and survival 12, 13 . In serch for more accurate tumor markers, particulary of bladder cancer, more detailed investigation of preoperative procoagulant and thrombophilic activity could help prediction of surgical outcome and choice of treatment options.
In the present study we examened association of preoperative plasma D-dimer level with tumor stage in patients who underwent radical cystectomy with urine derivation. We also examined prognostic significance of plasma Ddimer levels for occurance of postoperative complications and perioperative survivial. 
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MATERIALS AND METHODS
The conducted prospective randomised investigation of preoperative plasma D-dimer values in patients with bladder carcinoma who uderwent radical cystectomy in six months period at the Urologic Clinic of Institute of Urology and Nephrology, Clinical Center of Serbia. Of 54 bladder cancer patients 28 were excluded for following reasons: other surgery one month prior to radical cystectomy, presence of significant poreoperative uroinfection, previous chemotherapy and deep vein thrombosis. Preoperative plasma D-dimer level was measured, and postoperativelly patients were monitored for postoperative complications (infection, sepsis, venous thromboembolism and cardiologic events). Preoperative plasma D-dimer values in bladder carcinoma patients were compared with values in 20 patients with benign noninfective bladder disorders, such as stress incontinence prior to surgical treatment.
In order to measure plasma D-dimer level blood was obtained from cubital vein 24-72 hours prior to surgery. Levels of D-dimer were measured by quantative latex turbidimetric method on Behring Coagulation Timer. Because of sensitivity of assay all values below 50µg/l were set to equal 50 µg/l, cut-off value was set at 195 µg/l, while values over 500 µg/l were considered as significantly elevated. Data were statistically analised in SPSS ver.12 package, and values of p<0,05 were considered statistically significant.
RESULTS
Study group comprised 26 patients who underwent radical cystectomy with urinary diversion. There were 23 men and 3 woman. The mean age was 65,7, range 38-76 years. Average value of plasma D-dimer was 258,85+136,89 µg/l, comapred to 20 patients without bladder carcinoma in whom average plasma D-dimer was 155.14 + 47.207 µg/l (p,05). Approximatelly one third (34,6%) of bladder cancer patient had normal values of plasma D-dimer (• µg/l), while 65, 4% of them had elevated values of plasma D-dimer preoperativelly (331,35 +109,54µg/l), range 201-567µg/l. (Figure 1.) There was no statistically significant difference in plasma D-dimer level in grade 2 (15,4 %) and 3 (84,6 %) bladder cancer patients, 206µg/l and 268,5µg/l. Inspite small number of patients for definitive conclusions, 50% of grade 3 bladder carcinoma patients had elevated preoperative plasma D-dimer value over 200 µg/l.
Postoperativelly 12 patients (46,2%) had documented infection, 75% of them had elevated plasma D-dimer above cut-off value. Eight of them had signs of sepsis, and all patients who developed septic syndrome had preoperative plasma D-dimer value above normal range, average 298,6µg/l. Postoperative cardiovascular disorders with suspected thrombotic event occured in 3 patients, only one of them had elevated preoperative plasma D-dimer at 519µg/l. There were two lethal outcomes, one due to massive pulmonary embolism (normal preoperative plasma D-dimer) and one in sepsis with multiple organ failure ( preoperative plasma D-dimer 418 g/l). (Table 1 .)
It was significant that majority of patients who has documented infection and septic syndrome had preoperatively elevated plasma D-dimer levels. (Figure 2,3 .) Both patients with preoperative plasma D-dimer over 500 g/l developed serious infection, one died in septic sydrome.
DISCUSSION
Although small number of subjects did not provide statistical confirmation, data in this study indicate that majority of bladder cancer patients have increased plasma Ddimer preoperativelly (65,4%), and as patients in any state of health that could contribute to the activation of coagulation and fibrinolysis were excluded from the study, it seems that reason foe elevated specific fibrinolytic marker is malignancy. Plasma D-dimer is reported in other cancer patients as well, in patients with prostate cancer, colorectal cancer 9 , lung cancer, cervical cancer of uterus, ovarien malignancies, and in breast cancer. Increased concentration of coagulation activation markers in bladder carci- 
FIGURE 2 DIDSTRIBUTION OF NORMAL AND ELEVATED PREOP-ERATIVE PLASMA D-DIMER IN POSTOPERATIVE COM-PLICATIONS AFTER RADICAL CYSTECTOMY (NUMBER OF PATIENTS IN PERCENTAGE).
94 Elevated plasma D-dimer as a predictor of postoperative ACI Vol. LIV complications after radical cystectomy noma patients is connected with poor outcome of surgical treatment according to data published recently , . Postoperativelly 12 patients had documented infection, 75% of them with elevated preoperative plasma D-dimer above cut-off value. Eight of them had signs of sepsis, and all patients who developed septic syndrome had preoperative plasma D-dimer value above normal range, average 298,6 g/l. Untill recently data concerning urologic malignancies considered correlation of elevated plasma D-dimer in light of coagulation disorders and haemorrhagic complications, and this correlation has not been proved. But data indicate correlation of enhanced fibrinolysis as marker of severity of inflammational responce, with postoperative outcome in surgery. Average preoperative plasma D-dimer in this study was 296µg/l in patients who developed postopoerative complications, as in patients without complications plasma D-dimer was 206,4 µg/l (p).
Postoperative cardiovascular disorders with suspected thrombotic event occured in 3 patients, only one of them had elevated preoperative plasma D-dimer at 519µg/l. There were two lethal outcomes, one due to massive pulmonary embolism ( normal preoperative plasma D-dimer) and one in sepsis with multiple organ failure ( preoperative plasma D-dimer 418µg/l).
As small number of subjects reflects statistically insignificant correlation of preoperative elevation of plasma Ddimer and postoperative complications in bladder cancer patients, data shold be considered preliminary. However, preoperative determination of coagulation activation in patients sheduled for radical cystectomy raise important issues. Radical cystectomy as treatment option for advanced bladder carcinoma still carries certain burden of postoperativelly complicated course, and any improvement in decision makeng, with better insight in prognosis, can contribute in better quality of life and survivial of these patients.
CONCLUSION
If measurement of plasma D-dimer would be included in the rutine preoperative laboratory examination of patients with bladder cancer, it could provide supplementary information on tumor stage and prognosis. Although the number of patients in this study is not large enough to establish the usefulness of the measurement of preoperative plasma D-dimer levels, it appears that further prospective studies with a larger number of subjects would be worthwhile.
The issues that could contribute in prediction of treatment outcomes are determination of correlation of preoperativelly activated coagulation and fibrinolysis and susrvivial of patients undergoing radical surgery. Even more interesting would be determination of discriminative values of coagulation activation markers in means of confirmation of defencive systemic inflammatory responce, and early detection of postoperative complications.
SUMMARY POVI[ENE VREDNOSTI
PLAZMA D-DIMERA U PROCENI NASTANKA POSTOPERATIVNIH KOMPLIKACIJA POSLE RADIKALNE CISTETOMIJE U cilju prevencije nastanka komplikacija hirur{kog le~enja pa'ljivo preoperativno sagledavanje stanja zdravlja pacijenta se name}e kao osnovni korak. Medjutim, detaljna anamneza, standardni preoperativni fizikalni pregled i rutinski laboratorijski testovi ne pru'aju nam mogu}nost ta~nog preoperativnog predvidjanja nastanka komplikacija ili du'ine pre'ivljavanja. Preoperativno odredivanje tumorskih markera karcinoma mokra}ne be{ike samo donekle odra'ava uznapredovalost bolesti. Nova saznanja o patofiziolo{kim procesima u odgovoru organizma na stres, poreme}ajima hemostaze, sepsi, tromboembolizmu i malignitetu, ukazuju na zna~aj pojedinih markera koji bi mogli svojim prisustvom ili pove}anim koncentracijama u preoperativnom periodu ta~nije da uka'u na mogu}e pravce postoperativnog toka, du'inu pre'ivljavanja i pomognu u slo'enoj proceni boljitka od izabranog na~ina le~enja. Kako je odavno poznato da neoplasti~ne }elije pospe{uju stvaranje trombina i produkuju razne prokoagulante, detekcija stepena aktivacije koagu- 
